Commerzbank Aktiengesellschaft Incyte Corp Transaction History

Commerzbank Aktiengesellschaft

$3.75 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 29, 2020	SELL	$63.18 - $85.97 $3.4 Million - $4.62 Million	-53,779 Closed	0 $0
Q4 2019 Oct 03, 2024	BUY	$73.04 - $95.72 $3.93 Million - $5.15 Million	53,779 New	53,779 $4.7 Million
Q4 2019 Jan 17, 2020	BUY	$73.04 - $95.72 $1.02 Million - $1.34 Million	14,005 Added 35.21%	53,779 $4.7 Million
Q3 2019 Oct 03, 2024	BUY	$72.82 - $86.52 $2.9 Million - $3.44 Million	39,774 New	39,774 $2.95 Million
Q3 2019 Oct 17, 2019	BUY	$72.82 - $86.52 $669,507 - $795,464	9,194 Added 30.07%	39,774 $2.95 Million
Q2 2019 Oct 03, 2024	BUY	$73.52 - $88.7 $2.25 Million - $2.71 Million	30,580 New	30,580 $2.6 Million
Q2 2019 Jul 23, 2019	BUY	$73.52 - $88.7 $531,990 - $641,833	7,236 Added 31.0%	30,580 $2.6 Million
Q1 2019 Oct 03, 2024	BUY	$63.56 - $88.17 $1.48 Million - $2.06 Million	23,344 New	23,344 $2.01 Million
Q1 2019 May 13, 2019	SELL	$63.56 - $88.17 $2.03 Million - $2.82 Million	-32,016 Reduced 57.83%	23,344 $2.01 Million
Q4 2018 Oct 03, 2024	BUY	$58.5 - $69.94 $3.24 Million - $3.87 Million	55,360 New	55,360 $3.52 Million
Q4 2018 Feb 06, 2019	SELL	$58.5 - $69.94 $2.12 Million - $2.54 Million	-36,259 Reduced 39.58%	55,360 $3.52 Million
Q3 2018 Oct 04, 2024	BUY	$61.75 - $74.23 $5.66 Million - $6.8 Million	91,619 New	91,619 $6.33 Million
Q3 2018 Nov 13, 2018	SELL	$61.75 - $74.23 $519,008 - $623,903	-8,405 Reduced 8.4%	91,619 $6.33 Million
Q2 2018 Oct 04, 2024	BUY	$60.85 - $83.98 $6.09 Million - $8.4 Million	100,024 New	100,024 $6.7 Million
Q2 2018 Aug 10, 2018	BUY	$60.85 - $83.98 $546,737 - $754,560	8,985 Added 9.87%	100,024 $6.7 Million
Q1 2018 Oct 04, 2024	BUY	$83.06 - $100.98 $2.2 Million - $2.67 Million	26,459 Added 40.97%	91,039 $7.59 Million
Q1 2018 May 01, 2018	BUY	$83.06 - $100.98 $2.2 Million - $2.67 Million	26,459 Added 40.97%	91,039 $7.59 Million
Q4 2017 Oct 04, 2024	BUY	$93.56 - $116.6 $6.04 Million - $7.53 Million	64,580 New	64,580 $6.12 Million
Q4 2017 Jan 26, 2018	BUY	$93.56 - $116.6 $3.41 Million - $4.25 Million	36,478 Added 129.81%	64,580 $6.12 Million
Q3 2017 Nov 13, 2017	BUY	$109.15 - $138.27 $2.67 Million - $3.38 Million	24,463 Added 672.25%	28,102 $3.28 Million
Q2 2017 Aug 09, 2017	BUY	N/A	3,639	3,639 $458,000

Others Institutions Holding INCY

# of Institutions

657

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerzbank Aktiengesellschaft , based on Form 13F filings with the SEC.

News

Stay updated on Commerzbank Aktiengesellschaft with notifications on news.

Account